Matthias Guckenberger, Director of the Department of Radiation Oncology at University Hospital Zurich and Professor of Radiation Oncology, shared on LinkedIn:
“Best ever phone call by Christoph Wald, Hon FRCP(Glasg)
I am tremendously honored about the 2027 American College of Radiology Honorary Fellow designation.
Being recognized by a neighboring society and discipline feels incredible, as it reflects my philosophy and ESTRO presidential theme ‘Advancing Cancer Care and Radiation Oncology by Innovation and Partnership’
This designation is a moment to reflect and thank the people, institutions, societies and industry partners, which supported and enabled my clinical and scientific path
People: Huge thanks to all collaborators, colleagues, and coauthors, with a special mentioning of Nicolaus Andratschke , Stephanie Tanadini – Lang , Michael Flentje , and Panagiotis Balermpas
Institutions:
Klinik für Radio-Onkologie, USZ
Universitätsspital Zürich
University of Zurich
Comprehensive Cancer Center Zurich
Universitätsklinikum Würzburg
Julius-Maximilians-Universität Würzburg
The Royal Marsden NHS Foundation Trust
The Institute of Cancer Research
Societies:
European Society for Radiotherapy and Oncology (ESTRO)
American Society for Radiation Oncology (ASTRO)
Deutsche Gesellschaft für Radioonkologie (DEGRO) e. V.
SASRO – Scientific Association Of Swiss Radiation Oncology
EORTC – European Organisation for Research and Treatment of Cancer
ETOP IBCSG Partners Foundation
Cancer Research UK (CRUK)
Industry partners:
Siemens Healthineers and Varian
Elekta
AstraZeneca
Special thanks to
ACR Commission on Radiation Oncology, chair DAVID BEYER
ACR CARROS, chair Iris C. Gibbs.”
Other articles featuring Matthias Guckenberger on OncoDaily.